Drugmaker Pfizer has pulled the plug on its experimental twice-a-day weight loss pill - citing adverse side effects. The drug was meant to be entering phase-3 clinical trials. Toni Waterman has more.
IN: Pfizer says much…
DUR: 32s
OUT: SOC
http://www.fsnradionews.com/feeds/1201PfizerWeightLossPill-tw.mp3
IN: Pfizer says much…
DUR: 32s
OUT: SOC
http://www.fsnradionews.com/feeds/1201PfizerWeightLossPill-tw.mp3